SkyView Investment Advisors, LLC - COEPTIS THERAPEUTICS HLDGS I ownership

COEPTIS THERAPEUTICS HLDGS I's ticker is and the CUSIP is 19207A116. A total of 20 filers reported holding COEPTIS THERAPEUTICS HLDGS I in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
SkyView Investment Advisors, LLC ownership history of COEPTIS THERAPEUTICS HLDGS I
ValueSharesWeighting
Q3 2023$1
-75.0%
55,1220.0%0.00%
-100.0%
Q2 2023$4
-50.0%
55,1220.0%0.00%
-50.0%
Q1 2023$8
+33.3%
55,1220.0%0.00%0.0%
Q4 2022$6
-99.4%
55,122
+57.2%
0.00%
Q3 2022$1,00035,0700.00%
Other shareholders
COEPTIS THERAPEUTICS HLDGS I shareholders Q2 2023
NameSharesValueWeighting ↓
Ionic Capital Management LLC 418,728$41,8310.01%
METEORA CAPITAL, LLC 291,933$29,1640.01%
Kepos Capital LP 250,000$250.00%
Radcliffe Capital Management, L.P. 37,500$57,4240.00%
SkyView Investment Advisors, LLC 55,122$60.00%
Hunting Hill Global Capital, LLC 16,382$1,6370.00%
RIVERNORTH CAPITAL MANAGEMENT, LLC 150,000$15,0000.00%
CSS LLC/IL 73,748$14,7340.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
Virtu Financial LLC 20,693$20.00%
View complete list of COEPTIS THERAPEUTICS HLDGS I shareholders